Immunology Archives

Illustrated CareDx, Regeneron and Eupraxia representatives stand under spotlights with a DNA helix, laboratory flask and syringe, surrounded by digital medical displays and an applauding audience.

CareDx, Regeneron and Eupraxia Put Precision Medicine in the Spotlight -( $CDNA $EPRX $REGN $SNY )

by John F. Heerdink, Jr. October 31, 2026 452Views 0Likes

AlloSure Kidney Data Excites, Dupixent Sales Surge and POTENTIAL Competitor, EP-104GI, Nears December EoE Catalyst Biotechnology’s most persuasive growth stories are moving beyond laboratory promise and into financial statements, clinical evidence and approaching trial milestones. CareDx (NASDAQ: CDNA) reported third-quarter revenue growth…

Lycia Therapeutics Stock Jumps 67% in IPO Debut as Wall Street Backs a New Approach to Allergy Treatment ( $BBC $IBB $LYCA $XBI )

by John F. Heerdink, Jr. October 25, 2026 588Views 0Likes

An upsized $317.5 million offering gives Lycia Therapeutics (NASDAQ: LYCA) fresh capital to pursue protein-degrading medicines, with early human data and 2027 clinical milestones sharpening the investment story. October 24, 2026 Wall Street has found a biotechnology company with an unusually literal…

Biologics, Bulls, and Billion‑Dollar Plus Bets: AbbVie’s Immunology $10.9B ‘Durability’ Shopping Spree Explained -( $ABBV $APGE $EPRX $REGN $SNY )

by John F. Heerdink, Jr. June 22, 2026 461Views 0Likes

AbbVie’s latest deal signals that Big Pharma’s appetite for next‑gen immunology assets is not just alive, it is visibly bulking up for the long haul, and investors who ignore this corner of the market may find themselves benched just as the real…

Tag: Immunology

CareDx, Regeneron and Eupraxia Put Precision Medicine in the Spotlight -( $CDNA $EPRX $REGN $SNY )

Lycia Therapeutics Stock Jumps 67% in IPO Debut as Wall Street Backs a New Approach to Allergy Treatment ( $BBC $IBB $LYCA $XBI )

Biologics, Bulls, and Billion‑Dollar Plus Bets: AbbVie’s Immunology $10.9B ‘Durability’ Shopping Spree Explained -( $ABBV $APGE $EPRX $REGN $SNY )

Your Guide To Staying Informed In The Markets